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Supplementary figure 1. Rostroventral medulla serotonergic neuron innervation of the 
lumbar spinal dorsal horn 
(A) Brainstem RVM section from a P4 rat injected with Retrobeads into the lumbar dorsal horn at 
birth. Scale bar = 250µm. (A’) Excerpt from (A); Retrobead-containing cell bodies are green (blue 
arrow), serotonergic tryptophan hydroxylase (TPH+) cell bodies are red (yellow arrow; co-labelled 
cell = white arrow). Scale bar = 50µm. Quantification of the average number of TPH+ cells in the 
RVM demonstrated no change in the number of serotonergic neurons between P4 and P30 (B). 
The proportion of serotonergic neurons which project to the lumbar dorsal horn increased between 
P10 and P16 (C). Lumbar spinal cord sections were stained with 5-HT transporter (5-HTT) to label 
serotonergic terminals: example images from P7 (D) and adult P40 (E) rats are shown. Scale bar = 
250µm. Quantification of 5-HTT intensity in different dorsal horn laminae at different ages 
demonstrated 5-HTT intensity increases in different laminae and throughout the dorsal horn with 
age (F). Bars = mean ± SEM. ** P<0.01 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary figure 2.  Age and treatment interactions on vFh-evoked firing activity 
(A) Graph showing the effects of 5,7-DHT treatment on vFh-evoked firing activity at three 
ages, P8, P21 and adult.  Three-way ANOVA revealed significant effects of age and 5,7-
DHT treatment on vFh-evoked firing activity and (B) a significant age-treatment interaction 
when all five vFh data points are pooled. (C) Graph showing the effects of odansetron 
treatment (50µg) on vFh-evoked firing activity at two ages, P21 and adult.  Three-way 
ANOVA revealed significant effects of odensatron treatment on vFh-evoked firing activity 
and (D) a significant age-treatment interaction when all five vFh data points are pooled (see 
text for details). Bars = mean ± SEM. 
Supplementary Results 
Retrograde tracing and immunohistochemistry 
In retrograde tracing experiments, rats aged P0, P6 and P12 (n=4 per age) were anaesthetised with 
isoflurane (induction 4% in medical O2, maintenance 2.5%). An incision was made over the lumbar 4-
5 spinal dorsal horn and a small bilateral laminectomy was then made. A 500nl injection of 
microspheres (Retrobeads, Lumafluor) was made directly into the left lumbar 4-5 spinal dorsal horn 
using a 26 gauge Hamilton syringe. The needle was left in place for 30 seconds before withdrawal. 
P26 animals received intraspinal injection of 1µl of FluoroGold (Fluorochrome, n=4) instead of 
Microspheres, due to poor tracing efficacy of Microspheres in adult animals. The muscle and skin 
overlying the injection site was then sutured with 5-0 suture (Ethicon). 
Animals were perfused four days after intraspinal injections of retrograde tracers. Rats were 
anaesthetised with pentobarbitone sodium (500mg/kg) and transcardially perfused with heparinised 
saline (5000 IU/ml) followed by 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer. The brain and 
lumbar spinal cord were removed and postfixed overnight in 4% PFA and transferred to a 30% 
sucrose solution in 0.1M phosphate buffer solution (PBS) containing 0.01% sodium azide and stored 
at 4°C. Brain and spinal cord tissue was sectioned on a freezing microtome at 40μm and 30µm 
thicknesses, respectively. Brainstem sections were blocked with 3% goat serum in 0.3% Triton X-100 
in 0.1M PBS for 1h at room temperature, incubated overnight with tryptophan hydroxylase (TPH; 
mouse, 1:500, Sigma Aldrich), washed thrice with 0.1M PBS, then incubated with goat anti-mouse 
Alexafluor 594 (1:250).  
For spinal 5-HTT immunohistochemistry experiments, naïve P7, P14, P21 and P40 rats (n=4 per age) 
were perfused and lumbar spinal cord tissue was harvested. Sections were blocked with 3% goat 
serum in 0.3% Triton X-100 in 0.1M PBS for 1h at room temperature, incubated overnight with 5-HT 
transporter antibody (5-HTT; rabbit, 1:10000, Immunostar), washed thrice with 0.1M PBS, then 
incubated with goat anti-mouse Alexafluor 594 (1:250). Spinal cord sections from 5,7-DHT-treated 
rats were also labelled with 5-HTT to confirm ablation of serotonergic terminals (Fig 1A). All sections 
were washed after secondary antibody steps and mounted on gelatinised slides and were then cover 
slipped with Fluoromount (Sigma). Negative control stains omitting primary antibodies resulted in no 
immunofluorescence, demonstrating no non-specificity of any protocol. Sections were viewed using a 
Leica DMR light microscope, photographed using a Hamamatsu C4742-95 digital camera and 
analysed with Volocity Software 6.3. 
Immunohistochemistry data collection: In retrograde labelling experiments, TPH+ and 
Microsphere/Fluorogold & TPH-co-labelled cells were counted in the RVM. Data is expressed as the 
percentage of TPH+ cells which were retrogradely labelled, and was calculated as the number of 
Microsphere/FluoroGold & TPH+ cells divided by the number of TPH+ cells. Counts were performed 
in four sections per animals and were averaged to create one n per animal. For 5-HTT quantification, 
mean intensity was measured in 20µm x 30µm ROIs in lamina I, II, III and IV-V. The mean intensity of 
5-HTT for each sub-region of interest was measured using ImageJ/Fiji image analysis software. The 
intensities of 4-5 sections per animal were averaged to create one n value per animal. 
 
